Beijing Langkun Kangtai Pharmaceutical Technology Co., Ltd – Trademark Portfolio
Entity Type: 99
Beijing Langkun Kangtai Pharmaceutical Technology Co., Ltd holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 12 (Vehicles) — 2 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered and 1 is pending. Notable registered marks include APRILFUL and SKYMOBILITY. The owner is based in Fengtai , Beijing.
Shuanglin East Road, Xiaotun
2188, 2nd Floor, Building 3, No. 8
Fengtai , Beijing 100061 , CN
Showing of trademarks Trademarks
Trademark Classifications
Beijing Langkun Kangtai Pharmaceutical Technology Co., Ltd's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Frequently Asked Questions
How many trademarks does Beijing Langkun Kangtai Pharmaceutical Technology Co., Ltd have?
Beijing Langkun Kangtai Pharmaceutical Technology Co., Ltd has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 pending.
What trademark classes does Beijing Langkun Kangtai Pharmaceutical Technology Co., Ltd file in?
Beijing Langkun Kangtai Pharmaceutical Technology Co., Ltd files trademarks across 2 Nice Classification classes. The most active classes are Class 12 (Vehicles), Class 10 (Medical Apparatus). Class 12 covers vehicles; apparatus for locomotion by land, air or water.
What are Beijing Langkun Kangtai Pharmaceutical Technology Co., Ltd's most well-known trademarks?
Beijing Langkun Kangtai Pharmaceutical Technology Co., Ltd's registered trademark portfolio includes well-known marks such as APRILFUL and SKYMOBILITY. These are among 2 currently registered trademarks in the portfolio.
What is Beijing Langkun Kangtai Pharmaceutical Technology Co., Ltd's trademark registration success rate?
Beijing Langkun Kangtai Pharmaceutical Technology Co., Ltd has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 1 application is pending review.